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ABSTRACT
Background. Surgery proficiency gain curves must be
shortened to reduce patient harm during esophagectomy
learning.
Objective. This study aimed to test whether surgeon vol-
ume and surgeon age influenced the length of period of
surgical proficiency gain.
Methods. This population-based cohort study included
1384 patients with esophageal cancer who underwent
esophagectomy by any of the 36 highest-volume surgeons
in Sweden between 1987 and 2010, with follow-up until
2016. Annual surgeon volume was dichotomized by the
median values into ‘higher-volume surgeons’ (C 4 cases
per year) and ‘lower-volume surgeons’ (\ 4 cases per
year), and surgeon age at the start of practicing
esophagectomies into ‘younger surgeons’ (aged\ 45
years) and ‘older surgeons’ (aged C 45 years). Proficiency
gain curves were constructed using risk-adjusted cumula-
tive sum analysis for 1- to 5-year mortality (main outcome)
and secondary outcomes (presented below). The results
were adjusted for all established prognostic factors.
Results. For 1- to 5-year mortality, the change point was
at 14 cases among ‘higher-volume surgeons’, while ‘lower-
volume surgeons’ had a later change point at 31 cases. The
corresponding change points were at 13 cases among
‘younger surgeons’ and at 48 cases among ‘older sur-
geons’. Similar patterns of differences in the proficiency
gain curves were seen for the secondary outcomes of
30-day mortality and resection margin status (tumor
involvement).
Conclusion. Higher-volume- and younger surgeons seem
to have a substantially shorter period of proficiency gain
for long-term mortality and other outcomes following
surgery for esophageal cancer. This indicates a value of
intensified training of younger surgeons for these complex
operations.
Esophageal cancer is the 6th most common cancer death
globally,1 and the overall 5-year survival is \ 20%.2,3
Curative treatment is resectional surgery (esophagectomy),
usually in combination with neoadjuvant therapy.4 Profi-
ciency gain for esophagectomies performed by individual
surgeons influences both long- and short-term mortality.5
This needs to be solved to increase patient safety as sur-
geons gain proficiency in performing esophagectomy
independently. However, no studies have investigated
which factors affect surgical learning using clinical data.
Other studies have established the critical prognostic role
of individual surgeon volume (more than hospital vol-
ume),6 and how a certain surgeon age range (51–56 years)
may optimize long-term survival for patients with eso-
phageal cancer.7 The hypothesis of this study was that
proficiency gain for reaching stable long-term mortality
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would require fewer case numbers if the surgeons have a
higher annual volume of esophagectomies and are of lower
age. Proposed mechanisms would be that learning is more
effective if many operations are performed with greater
intensity of practice, and that younger surgeons may be
more receptive and more quickly learn to perform new and
complex procedures. We also hypothesized that short-term
mortality, rate of reoperations, rate of resection margin
with cancer involvement, and lymph node harvest would be
influenced by surgical proficiency gain. The aim of this
study was to assess how annual surgeon volume and sur-
geon age influence the proficiency gain curves among
surgeons performing resectional surgery for esophageal
cancer.
METHODS
Design
This was a population-based cohort study based on an
updated version of a well-established Swedish cohort,
which contains 98% of all surgically treated patients with
esophageal cancer (adenocarcinoma or squamous cell car-
cinoma) in Sweden between 1987 and 2010, with follow-
up until 31 May 2016.5 The study was approved by the
Regional Ethical Review Board in Stockholm, Sweden.
Source Cohort
The source cohort contained 1820 patients who under-
went open esophagectomy for esophageal cancer during the
study period. A detailed description is available else-
where.5,8–10 In brief, patients diagnosed with esophageal
cancer were identified from the Swedish Cancer Registry,
which is 98% complete for esophageal cancer in Sweden.11
The Swedish National Patient Registry was used to identify
patients who had undergone esophagectomy for cancer, for
which the registry is 99.6% complete.12 The Patient Reg-
istry also provided complete and accurate information on
medical comorbidities.13 Additionally, medical records for
each patient were collected from Swedish hospitals: oper-
ation charts provided surgical approach, surgeon names, and
annual surgeon volume, and data on tumor stage and his-
tology were retrieved from histopathological records of the
resected tumor specimens. The most common surgical
procedure was a combined open abdominal and transtho-
racic approach (95%). Tumor stage was defined according to
the TNM classification of the International Union Against
Cancer.14 The Longitudinal Integration Database for Health
Insurance and Labor Market Studies provided information
on the educational level of patients. Finally, the Swedish
Cause of Death Registry, which is above 99% complete,15
provided date of death with follow-up until 31 May 2016.7
All data sources were cross-linked using the Swedish per-
sonal identity numbers, which are uniquely assigned to
every Swedish resident at birth or immigration.16
Study Cohort
For this study, birth dates of the surgeons were col-
lected, which were retrieved from the Swedish Registry of
Licensed Health and Medical Care Personnel, and used to
calculate surgeon age. This registry was also used to collect
the date of obtained specialist competence for each sur-
geon. The source cohort contained 139 surgeons, most of
whom had small case series. The 36 surgeons with the
largest case series (details given below) were included in
this study. The other 103 surgeons were excluded due to
insufficient cumulative volume to reach a plateau in the
proficiency gain curves.
Exposures
Exposures were annual surgeon volume and surgeon
age. Annual surgeon volume was calculated by dividing the
total number of operations for each surgeon by the number
of years of practice. Years of practice was defined as date
of specialization until retirement, assumed to be at 65 years
of age, limited by the time period of the study. Surgeon age
was defined as the age that each surgeon performed their
first esophagectomy in the cohort. Using the median values
as cut-offs, the 36 included surgeons were dichotomized
into two groups of 18 surgeons for each exposure. Annual
surgeon volume was categorized into ‘higher-volume sur-
geons’ (C 4 cases per year) and ‘lower-volume surgeons’
(\ 4 cases per year), and surgeon age was categorized into
‘younger surgeons’ (\ 45 years) and ‘older surgeons’
(C 45 years). Each surgeon had no experience prior to
inclusion in the study because the primary surgeon had not
conducted any esophagectomies for cancer before baseline.
To further contrast the effects of the exposures, the
surgeons were also divided into tertiles, with 12 surgeons
in each group for each exposure. In these analyses, annual
surgeon volume was divided into groups with median
annual volume of 2, 4, and 6 cases, and surgeon age was
divided into groups of median ages of 38, 40, and 44 years.
Outcomes
The main outcome was the number of cases of the
proficiency gain curve to obtain a plateau in 1- to 5-year
all-cause mortality rate following surgery. The four sec-
ondary outcomes were the case numbers of the proficiency
gain curve needed for a stable 30-day all-cause mortality,
reoperation rate (for any indication), resection margin
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status (R0 vs. R1), and total lymph node yield. A resection
margin of R1 corresponded to microscopically visible
tumor at the resection margin, and R0 represented no such
tumor involvement.17
Statistical Analysis
Follow-up was counted from the date of surgery until
death, emigration, or end of study (31 May 2016), which-
ever occurred first. The operated patients were aligned in
chronological order for each surgeon, from first to last. To
identify the case numbers of the proficiency gain curves in
the exposure groups, a combination of risk-adjusted
cumulative sum (RA-CUSUM) and change-point analysis
was performed. The RA-CUSUM curves were generated
for the cumulative difference between the observed and the
expected outcomes against patient number.18 The curves
were plotted using the RA-CUSUM equation Si = Si-1
? (R––RR), where S0 = 0, Si is the risk-adjusted cumula-
tive sum at case number i, Ri is the sum of the observed
outcome at case number i, and RR is the sum of expected
outcome at case number i. The curve goes upwards if the
outcome is greater than expected, and downwards if less
than expected. The expected probability for each case was
calculated using multivariable logistic regression models.
Seven potential confounding factors were adjusted for in
the models: tumor stage (0–I, II, III, or IV),10 histological
subtype (adenocarcinoma or squamous cell carcinoma),19
age of the patient (continuous),10 sex of the patient (male or
female),10 use of neoadjuvant therapy (yes or no),20
Charlson comorbidity index score (0, 1, or C 2, excluding
esophageal cancer),10,21 and formal education of patients
(\ 10 years, 10–12 years, or[ 12 years).22
The change point was defined as the patient number at
which there was a sustained improvement in outcome. This
was represented graphically on the RA-CUSUM curve as
the maximal deflection of the curve, i.e. the point at which
the outcome changed from worse to better than expected.
The clinical significance of the change point was deter-
mined by comparing the outcomes before and after the
identified change point. The results were also compared
using the two-sided Mann–Whitney U test for continuous
outcomes, and two-sided Chi square test for binomial
outcomes, with a significance level of p\ 0.05.
RESULTS
Patients
Of 1820 patients in the source cohort, the 36 partici-
pating surgeons performed esophagectomies in 1384
patients (76.0%). Characteristics of these 1384 study
patients are presented in Table 1. The median age was
66 years and the largest categories were male sex (74.2%),
\ 10 years of education (47.8%), no comorbidity [Charl-
son score 0] (56.6%), adenocarcinoma histology (54.8%),
tumor stage II or III (68.2%), and no neoadjuvant therapy
(66.9%).
Surgeons
Among the 36 participating surgeons, ‘higher-volume
surgeons’ performed a median annual volume of five cases
(interquartile range [IQR] 4–6), whereas ‘lower-volume
surgeons’ performed a median annual volume of two cases
(IQR 1–3). ‘Younger surgeons’ had a median age of
40 years (IQR 37–42 years) at the first performed case
compared with 47 years (IQR 46–53) for ‘older surgeons’.
Annual Surgeon Volume and Proficiency Gain Curves
Mortality Within 1–5 Years of Surgery For ‘higher-
volume surgeons’, the change point for 1- to 5-year
mortality was at 14 cases (Fig. 1a), where the mortality
TABLE 1 Characteristics of study participants having undergone
esophagectomy for esophageal cancer in Sweden
Variable No. of patients (%)
Total 1384 (100.0)
Age, years [median (interquartile range)] 66 (59–72)
Sex
Male 1027 (74.2)
Female 357 (25.8)
Years of formal education
\ 10 662 (47.8)
10–12 494 (35.7)
[ 12 189 (13.7)
Charlson comorbidity score
0 784 (56.6)
1 289 (20.9)
C 2 311 (22.5)
Histological subtype
Adenocarcinoma 759 (54.8)
Squamous cell carcinoma 622 (44.9)
Tumor stage
0–I 336 (24.2)
II 507 (36.6)
III 437 (31.6)
IV 99 (7.2)
Neoadjuvant therapy
Yes 458 (33.1)
No 926 (66.9)
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decreased from 67.2% to 57.1% (p = 0.049) [Table 2]. For
‘lower-volume surgeons’, the change point was at 31 cases
(Fig. 1a), where the mortality decreased from 67.8 to
64.9% (p = 0.875) [Table 2].
30-Day Mortality For ‘higher-volume surgeons’, the
change point for 30-day mortality was at 16 cases
(Fig. 1b), where the mortality decreased from 4.5 to
2.5% (p = 0.047) [Table 2]. For ‘lower-volume
surgeons’, the corresponding change point was at 37
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FIG. 1 Proficiency gain curves
in relation to ‘higher-volume
surgeons’ (yellow lines) and
‘lower-volume surgeons’ (blue
lines) in relation to a 1- to
5-year mortality, showing
change point for ‘higher-volume
surgeons’ at 14 cases and
‘lower-volume surgeons’ at 31
cases; b 30-day mortality,
showing change point for
‘higher-volume surgeons’ at 16
cases and ‘lower-volume
surgeons’ at 37 cases;
c reoperation rate, showing no
change points; d R1 resection
margin, showing change point
for ‘higher-volume surgeons’ at
16 cases and ‘lower-volume
surgeons’ at 22 cases; e lymph
node yield, showing no change
points. CUSUM cumulative sum
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cases (Fig. 1b), where the mortality decreased from 5.3 to
3.6% (p = 0.502) [Table 2].
Reoperation Rate The reoperation rate was 7.7% for
‘higher-volume surgeons’ compared with 15.2% for
‘lower-volume surgeons’ (p\ 0.001), but there were no
identifiable change points for either curve (Fig. 1c).
Resection Margin Status For ‘higher-volume surgeons’,
the change point for the R1 resection margin status was at
16 cases (Fig. 1d), where it decreased from 20.9 to 13.0%
(p = 0.027) [Table 2]. For ‘lower-volume surgeons’, the
corresponding change point was at 22 cases (Fig. 1d),
where it decreased from 21.5 to 16.0% (p = 0.081)
[Table 2].
Lymph Node Yield The number of lymph nodes removed
and examined was higher for ‘higher-volume surgeons’
(median 11 [IQR 5–20]) compared with ‘lower-volume
surgeons’ (median 5 [IQR 3–11]) (p\ 0.001), but no
change points were present in the graphs (Fig. 1e).
Surgeon Age and Proficiency Gain Curves
Mortality Within 1–5 Years of Surgery For ‘younger
surgeons’, the change point for 1- to 5-year mortality was
at 13 cases (Fig. 2a), where the mortality decreased from
63.4 to 56.9% (p = 0.191) [Table 3]. For ‘older surgeons’,
the corresponding change point was at 48 cases (Fig. 2a),
where the mortality decreased from 65.5 to 52.2%
(p = 0.201) [Table 3].
30-Day Mortality For ‘younger surgeons’, the change
point for 30-day mortality was at 18 cases (Fig. 2b), where
the mortality decreased from 5.2 to 2.4% (p = 0.027)
[Table 3]. For ‘older surgeons’, the corresponding change
point was at 31 cases (Fig. 2b), where the mortality
decreased from 5.7 to 2.9% (p = 0.237) [Table 3].
Reoperation Rate There was no obvious change point for
‘younger surgeons’ (Fig. 2c). ‘Older surgeons’ had a
change point for reoperation rate at 36 cases, where it
decreased from 14.4 to 9.8% (p = 0.265). However,
‘younger surgeons’ had a lower reoperation rate (9.3%)
than ‘older surgeons’ (13.6%) [p = 0.015].
Resection Margin Status For ‘younger surgeons’, the
change point for the R1 resection margin was at 7 cases
(Fig. 2d), where it decreased from 18.8 to 14.9%
(p = 0.290) [Table 3]. For ‘older surgeons’, two change
points were present, one at 16 cases and the other at 56
cases (Fig. 2d), where it decreased from 25.0 to 17.4%
(p = 0.067) and 21.3–18.2% (p = 0.802), respectively
(Table 3).
Lymph Node Yield Regarding lymph node yield, no
change points were present for ‘younger’ or ‘older’
surgeons (Fig. 2e). However, the number of lymph nodes
removed and examined was higher for ‘younger surgeons’
(median 11 [IQR 5–20]) compared with ‘older surgeons’
(median 5 [IQR 3–9]) [p\ 0.001].
TABLE 2 Outcomes among 1384 patients having undergone esophagectomy for esophageal cancer before and after change points in
proficiency gain curves, comparing 18 ‘higher-volume surgeons’ with 18 ‘lower-volume surgeons’
Outcome Annual
volume
Proficiency gain curve change point
(n)
Percentage with outcome (number/total number)
Before change
point
After change
point
Change-point
p value
1- to 5-year
mortality
Higher 14 67.2% (82/122) 57.1% (216/378) 0.049
Lower 31 67.8% (187/276) 64.9% (50/77) 0.875
30-day mortality Higher 16 4.5% (10/221) 2.5% (15/589) 0.047
Lower 37 5.3% (26/490) 3.6% (3/84) 0.502
Reoperation rate Higher No NA NA NA
Lower No NA NA NA
R1 resection margin Higher 16 20.9% (49/235) 13.0% (62/476) 0.027
Lower 22 21.5% (50/233) 16.0% (40/252) 0.081
Lymph node yield Higher No NA NA NA
Lower No NA NA NA
NA not applicable
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Proficiency Gain Curves of Volume and Age Tertiles
The RA-CUSUM curves of the tertiles consistently
demonstrated that ‘higher-volume surgeons’ and ‘younger
surgeons’ had earlier change points than their respective
counterparts, with the middle tertile change points in
between (electronic supplementary material). Change-point
analyses were not repeated due to few numbers in each
tertile.
DISCUSSION
This study indicates that higher-volume surgeons and
younger surgeons have shorter proficiency gain curves for
long-term survival following surgery for esophageal cancer
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FIG. 2 Proficiency gain curves
in relation to ‘younger
surgeons’ (yellow lines) and
‘older surgeons’ (blue lines) in
relation to a 1- to 5-year
mortality, showing change point
for ‘younger surgeons’ at 13
cases and ‘older surgeons’ at 48
cases; b 30-day mortality,
showing change point for
‘younger surgeons’ at 18 cases
and ‘older surgeons’ at 31 cases;
c reoperation rate, showing no
change point for ‘younger
surgeons’ and for ‘older
surgeons’ at 36 cases; d R1
resection margin, showing
change point for ‘younger
surgeons’ at 7 cases and ‘older
surgeons’ at 16 and 56 cases;
e lymph node yield, showing no
change points. CUSUM
cumulative sum
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than lower-volume surgeons and older surgeons, respec-
tively. Similar improvements were seen in the proficiency
gain curves for 30-day mortality and resection margin
status. The reoperation rates were lower and lymph node
yield was higher for higher-volume surgeons and younger
surgeons compared with their respective comparison
groups, but no change points were identified.
Advantages of the study include the population-based
design with a high (98%) participation rate and long and
complete follow-up of all patients, and the usage of accu-
rate and complete patient and surgeon data on exposures,
outcomes, and confounders. Limitations include the retro-
spective design that possibly prevents collection and
examination of all potential confounding variables. How-
ever, the data assessment was comprehensive and included
the medical records of all patients. Although it is possible
that the defined case 1 may not have been the first case
performed by the surgeons, the long study period (from
1987 onwards) meant that this might have occurred only in
a minority of cases. The cut-offs for defining ‘higher-vol-
ume surgeons’ and ‘younger surgeons’ were based on the
median values and may not be representative of other
datasets, limiting the external validity of the results. As in
any observational study, there might have been unknown
selection bias and confounding, including selection of
cases to certain experienced surgeons, as well as changes
that occurred during the long study period. However, the
results were adjusted for all established prognostic fac-
tors,10,19,20,22 which is a major strength. The vast majority
of the operations within the Swedish population cohort was
performed by the 36 included surgeons. Nevertheless, the
total number of surgeons analyzed was limited, which
reduced the statistical power, and might explain why some
change points were not statistically significant. However,
the change points were evident from the RA-CUSUM plots
and followed a distinct and consistent pattern for surgeon
volume and starting surgeon age on the case numbers of the
proficiency gain curves. The difference in annual volume
between the higher- and lower-volume surgeons was small,
but the study detected substantial differences in case
numbers at which the surgeons reached a stable plateau for
most outcomes. This is also true regarding surgeon age;
however, this study does not demonstrate the optimal
annual volume or surgeon age. It may be that even younger
and higher-volume surgeons learn faster than shown by this
study. The training period or residency was not captured
within the present study; however, none of the surgeons
had any past primary surgeon experiences of esophagec-
tomies prior to being included in the study. Similarly, the
age of each surgeon was defined at case 1, meaning that the
older surgeons in the study are only more senior by age, but
not by experience. Therefore, it is unlikely that there is bias
due to the difficulty of cases. In addition, the curves were
risk-adjusted according to the case demographics available,
which were comprehensive for case complexity. The study
period was from 1987 to 2010, which preceded central-
ization of esophageal cancer surgical services in Sweden.
However, in the current era, surgeons more commonly
operate in teams, and the proficiency gain curves in future
may need to be modeled by teams rather than individual
surgeons.
The role of proficiency gain curves in the long-term
prognosis following esophagectomy has been examined
based on an earlier version of the cohort used for the
TABLE 3 Outcomes among 1384 patients having undergone esophagectomy for esophageal cancer before and after change points in
proficiency gain curves, comparing 18 ‘younger surgeons’ with 18 ‘older surgeons’
Outcome Age group Proficiency gain curve change point (n) Percentage with outcome (number/total number)
Before change point After change point Change-point p value
1- to 5-year mortality Younger 13 63.4% (78/123) 56.9% (257/452) 0.191
Older 48 65.5% (167/255) 52.2% (12/23) 0.201
30-day mortality Younger 18 5.2% (15/288) 2.4% (15/625) 0.027
Older 31 5.7% (21/366) 2.9% (3/105) 0.237
Reoperation rate Younger No NA NA NA
Older No NA NA NA
R1 resection margin Younger 7 18.8% (21/112) 14.9% (103/693) 0.290
Older (1)a 16 25.0% (49/196) 17.4% (34/195) 0.067
Older (2)a 56 21.3% (81/380) 18.2% (2/11) 0.802
Lymph node yield Younger No NA NA NA
Older No NA NA NA
NA not applicable
aTwo change points
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present study.5 The study found that prognosis was better
after the proficiency gain curve had been completed. This
indicates that patient safety is compromised during surgical
proficiency gain and that patients can benefit from more
efficient surgical learning. Previous studies have shown
improved long-term survival for surgeons with higher
volume for esophagectomies.8,23,24 Importantly, in the
same cohort we have clearly shown greater prognostic
importance of surgeon volume over hospital volume, and
thus the present study focused on the influence of surgeon
volume on the proficiency gain curve.8 A study on surgeon
age showed that both short- and long-term survival after
esophagectomies was better for surgeons aged
52–56 years.7 This is possibly explained by a trade-off
between accumulated competence and decreased technical
skills and concentration with increased age.
To the best of our knowledge, this is the first study
investigating how proficiency gain curves are influenced by
annual surgeon volume and surgeon age. A possible
explanation for the ‘surgeon volume effect’ is that a higher
annual volume during a shorter time period facilitates a
more effective acquirement of new skills. A possible
explanation for the results regarding surgeon age is that
younger surgeons may be more responsive to obtaining
new skills, both intellectually and practically, relative to
their older counterparts. As the age of each surgeon was
defined at their case 1, referral of more complicated cases
to older surgeons cannot explain the results.
The findings of this study suggest the need to establish
systematic training programs for selected surgeons to
conduct esophagectomies in order to minimize learning-
associated mortality. The results suggest that cases should
be converged towards fewer and possibly younger sur-
geons, providing them with adequate volume within a
shorter period of time. Collaboration between hospitals, or
centralization of esophagectomies to high-volume hospi-
tals, may be needed to provide a sufficient procedural
volume during a limited period of training. Although the
present study only included open esophagectomies, it is
possible that the results can also be applied to minimally
invasive esophagectomies, but future studies are needed to
examine this more closely.
CONCLUSION
This comprehensive nationwide Swedish cohort study
indicates that higher annual surgeon volume and younger
surgeon age shortens proficiency gain curves of open
esophagectomies for esophageal cancer. This indicates the
need for well-organized and intense training of surgeons in
esophageal cancer surgery.
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